Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway

被引：0
|
作者：
Guangyan Zhangyuan
Fei Wang
Haitian Zhang
Runqiu Jiang
Xuewen Tao
Decai Yu
Kangpeng Jin
WeiWei Yu
Yang Liu
Yin Yin
Jintao Shen
Qinfeng Xu
Wenjie Zhang
Beicheng Sun
机构：
[1] Nanjing Medical University,Department of Hepatobiliary Surgery of Drum Tower Clinical Medical College
[2] The Affiliated Drum Tower Hospital of Nanjing University Medical School,Department of Hepatobiliary Surgery
[3] Nanjing Medical University,Liver Transplantation Center of the First Affiliated Hospital and State Key Laboratory of Reproductive Medicine
[4] The Affiliated Drum Tower Hospital of Nanjing University Medical School,Department of Nuclear Medicine
来源：
Oncogene | 2020年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
引用
收藏
页码：1388 / 1388
相关论文
共 50 条
  • [1] VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway
    Guangyan Zhangyuan
    Fei Wang
    Haitian Zhang
    Runqiu Jiang
    Xuewen Tao
    Decai Yu
    Kangpeng Jin
    WeiWei Yu
    Yang Liu
    Yin Yin
    Jintao Shen
    Qinfeng Xu
    Wenjie Zhang
    Beicheng Sun
    [J]. Oncogene, 2020, 39 : 1213 - 1230
  • [2] VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway
    Zhangyuan, Guangyan
    Wang, Fei
    Zhang, Haitian
    Jiang, Runqiu
    Tao, Xuewen
    Yu, Decai
    Jin, Kangpeng
    Yu, WeiWei
    Liu, Yang
    Yin, Yin
    Shen, Jintao
    Xu, Qinfeng
    Zhang, Wenjie
    Sun, Beicheng
    [J]. ONCOGENE, 2020, 39 (06) : 1213 - 1230
  • [3] NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
    Gong, Chengwu
    Ai, Jiyuan
    Fan, Yun
    Gao, Jun
    Liu, Weiwei
    Feng, Qian
    Liao, Wenjun
    Wu, Linquan
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 8537 - 8552
  • [4] Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway
    Hou, Teng
    Zhou, Lijie
    Wang, Longwang
    Kazobinka, Gallina
    Chen, Yumao
    Zhang, Xiaoping
    Chen, Zhaohui
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (06) : 2250 - 2260
  • [5] APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target
    Chen, Huarong
    Wong, Chi-Chun
    Liu, Dabin
    Go, Minnie Y. Y.
    Wu, Bin
    Peng, Sui
    Kuang, Ming
    Wong, Nathalie
    Yu, Jun
    [J]. THERANOSTICS, 2019, 9 (18): : 5246 - 5260
  • [6] LINC01370 suppresses hepatocellular carcinoma proliferation and metastasis by regulating the PI3K/AKT pathway
    Xiao, Fei
    Zhang, Zhuoyun
    Li, Luqian
    He, Xiaojie
    Chen, Yufeng
    [J]. DISCOVER ONCOLOGY, 2024, 15 (01)
  • [7] ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma
    Longyan Ran
    Xiao Mou
    Zhenglin Peng
    Xiaochen Li
    Meirong Li
    Duo Xu
    Zixi Yang
    Xingwang Sun
    Tao Yin
    [J]. Scientific Reports, 13 (1)
  • [8] ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma
    Ran, Longyan
    Mou, Xiao
    Peng, Zhenglin
    Li, Xiaochen
    Li, Meirong
    Xu, Duo
    Yang, Zixi
    Sun, Xingwang
    Yin, Tao
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01):
  • [9] ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
    Ni, Sheng
    Wei, Qian
    Yang, Li
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 12409 - 12419
  • [10] Overexpression of Rab40b Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway
    Shi, Li-Wei
    Zhao, Zhi-Bo
    Zhong, Li
    Gao, Jian
    Gong, Jian-Ping
    Chen, Hang
    Min, Yu
    Zhang, Yi-Yin
    Li, Zhi
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 10139 - 10150
12345